MannKind Corp (MNKD)
4.62
+0.15
(+3.36%)
USD |
NASDAQ |
Mar 18, 16:00
4.66
+0.04
(+0.87%)
After-Hours: 20:00
MannKind Enterprise Value: 1.182B for March 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 15, 2024 | 1.182B |
March 14, 2024 | 1.190B |
March 13, 2024 | 1.215B |
March 12, 2024 | 1.177B |
March 11, 2024 | 1.220B |
March 08, 2024 | 1.399B |
March 07, 2024 | 1.366B |
March 06, 2024 | 1.272B |
March 05, 2024 | 1.258B |
March 04, 2024 | 1.231B |
March 01, 2024 | 1.190B |
February 29, 2024 | 1.085B |
February 28, 2024 | 1.034B |
February 27, 2024 | 995.78M |
February 26, 2024 | 941.70M |
February 23, 2024 | 933.58M |
February 22, 2024 | 944.40M |
February 21, 2024 | 947.11M |
February 20, 2024 | 947.11M |
February 16, 2024 | 960.63M |
February 15, 2024 | 975.43M |
February 14, 2024 | 945.72M |
February 13, 2024 | 891.72M |
February 12, 2024 | 964.63M |
February 09, 2024 | 921.42M |
Date | Value |
---|---|
February 08, 2024 | 899.82M |
February 07, 2024 | 899.82M |
February 06, 2024 | 907.92M |
February 05, 2024 | 851.21M |
February 02, 2024 | 859.31M |
February 01, 2024 | 894.42M |
January 31, 2024 | 875.52M |
January 30, 2024 | 894.42M |
January 29, 2024 | 924.12M |
January 26, 2024 | 878.22M |
January 25, 2024 | 902.52M |
January 24, 2024 | 899.82M |
January 23, 2024 | 905.22M |
January 22, 2024 | 905.22M |
January 19, 2024 | 880.92M |
January 18, 2024 | 878.22M |
January 17, 2024 | 859.31M |
January 16, 2024 | 872.81M |
January 12, 2024 | 897.12M |
January 11, 2024 | 910.62M |
January 10, 2024 | 943.02M |
January 09, 2024 | 937.62M |
January 08, 2024 | 975.43M |
January 05, 2024 | 956.53M |
January 04, 2024 | 1.005B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
247.88M
Minimum
Jun 26 2019
1.593B
Maximum
Aug 08 2023
892.45M
Average
1.023B
Median
Nov 03 2022
Enterprise Value Benchmarks
United Therapeutics Corp | 8.802B |
Corcept Therapeutics Inc | 2.033B |
Cassava Sciences Inc | 798.26M |
Amphastar Pharmaceuticals Inc | 2.404B |
Cogent Biosciences Inc | 526.91M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 1.401M |
Revenue (Quarterly) | 58.47M |
Total Expenses (Quarterly) | 47.84M |
EPS Diluted (Quarterly) | 0.01 |
Gross Profit Margin (Quarterly) | 69.10% |
Profit Margin (Quarterly) | 2.40% |
Earnings Yield | -0.87% |
Operating Earnings Yield | 0.82% |
Normalized Earnings Yield | -0.7352 |